Phone: (856) 200-8392 | Fax: (856) 288-1672 | info@insightspeechandswallowing.com | Location: Cherry Hill, NJ

Insight Speech and Swallowing Therapy

When weekly therapy isn't enough, it's time to go all in.
Intensive Therapy Program
Focused, intensive speech and swallowing therapy designed to help adults make meaningful progress toward the communication, cognitive, and swallowing goals that matter most in everyday life.
Limited enrollment • South Jersey + Philadelphia region • Select programs available virtually
Intensive Brain
Injury Program
Our Intensive Brain Injury Program is a highly immersive and personalized rehabilitation experience designed for individuals following acquired or traumatic brain injury
Unlike traditional therapy provided once or twice per week, this intensive model delivers concentrated treatment over several hours across several weeks to accelerate progress and maximize communication opportunities. Participants engage in a combination of individual therapy, group treatment, technology-based practice, and communication partner training.
Participants benefit from direct access to specialized brain injury expertise and a consistent therapeutic approach throughout the program. Every aspect of treatment is individualized to support meaningful communication goals, whether returning to school or work, participating in conversations, engaging in community activities, or increasing confidence in daily life.
Program Details:
-
Structured Rehabilitation Cohorts for Return to Work & School
-
3-hour sessions, 3 days per week
-
2-, 3-, and 4-week cohort options
-
Structured cognitive retraining sessions
-
Functional communication practice
-
Executive functioning and memory strategy training
-
Technology-based supports and carryover programming
-
Caregiver education and participation sessions
-
Pre- and post-program functional assessment

Your Investment
2 Week Reset:
$3,750
3 Week Return-to-Function:
$5,500
4 Week Comprehensive Cognitive Recovery Program:
$6,950
November 2026 Cohort
1 space remaining
December 2026 Cohort
1 space remaining
